1. Crawford JD. Treatment of tall girls with estrogen. Pediatrics. 1978;62(Suppl 2):1189-1195.
2.
2. Prader A, Zachmann M. Treatment of excessively tall girls and boys with sex hormones. Pediatrics. 1978;62(Suppl 2):1202-1209.
3.
3. Tauber M, Pienkowski C, Rochiccioli P. Growth hormone secretion in children and adolescents with familial tall stature. Eur J Pediatr. 1994;53:311-316.
4.
4. Hindmarsh PC, Stanhope R, Kendall BE, Brook CG. Tall stature: a clinical, endocrinological and radiological study. Clin Endocrinol. 1986;25:223-231.
5.
5. Theintz GE, Tang JZ, Marti C, et al. Growth hormone response to thyrotropin-releasing hormone in children and adolescents: a reappraisal. Acta Endocrinol. 1986;279(Suppl):51-59.
6.
6. Stanhope R, Hindmarsh P, Kendall B, Brook CG. High resolution CT scanning of the pituitary gland in growth disorders. Acta Paediatr Scand. 1986;75:779-786.
7.
7. Dickerman Z, Loewinger J, Laron Z. The pattern of growth in children with constitutional tall stature form birth to age 9 years. A longitudinal study. Acta Paediatr Scand. 1984;73:530-536.
8.
8. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd ed.Stanford, CA: Stanford University Press; 1959.
9.
9. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952;40:423-441.
10.
10. Tanner JM, Whitehouse RH, Marshall WA, et al. Assessment of Skeletal Maturity and Prediction of Adult Height (TW 2 Method). London, New York: Academic Press; 1975.
11.
11. Roche AF, Wainer W, Thissen D. Predicting Adult Stature for Individuals. Monographs in Pediatrics 3. Basel, Switzerland: S. Karger Ag, Karger; 1974.
12.
12. Hernindez M, Sanchez E, Sobradillo B, Ricon J. Skeletal Maturation and Height Prediction-Atlas and Scoring Methods. Madrid: Dfaz de Santos, S.A.; 1991.
13.
13. Joss EE, Temperli R, Mullis PE. Adult height in constitutionally tall stature: accuracy of five different height prediction methods. Arch Dis Child. 1992;67:1357-1362.
14.
14. Tanner JM, Whitehouse RH, Marshall WA, Carter BS. Prediction of adult height from height, bone age and the occurrence of menarche, at ages 4 to 16 with allowance for midparent height. Arch Dis Child. 1975;50:14-26.
15.
15. DeWaal WJ, Greyn-Fokker MH, Stijnen TH, et al. Accuracy of height prediction and effect of growth-reductive therapy in 362 constitutionally tall childrenJ Clin Endocrinol Metab. 1996;81:1206-1216.
16.
16. Goldzieher MA. Treatment of excessive growth in the adolescent female. J Clin Endocrinol. 1956;16:249-249.
17.
17. Bierich JR. Estrogen treatment of girls with constitutional tall stature. Pediatrics. 1978;62(Suppl 2):1196-1201.
18.
18. Zachmann M, Ferrandez A, Murset G, Prader A. Estrogen treatment of excessively tall girls. Helv Paediatr Acta. 1975;30:11-30.
19.
19. Wettenhall HN, Cahill C, Roche AF. Tall girls: a survey of 15 years of management and treatmentJ Pediatr. 1975;86:602-610.
20.
20. Schoen EJ, Solomon IL, Warner O, Wingerd J. Estrogen treatment of tall girls. Am J Dis Child. 1973;125:71-74.
21.
21. Whitelaw MJ. Experiences in treating excessive height in girls with cyclic oestradiol valerate. Acta Endocrinol. 1967;54:473-484.
22.
22. Kroc Foundation conference: Estrogen treatment of the young. Pediatrics. 1978;62(Suppl):1087-1217.
23.
23. Conte FA, Grumbach MM. Estrogen use in children and adolescents: a survey. Pediatrics. 1978;62(Suppl):1091-1097.
24.
24. Kuhn N, Blunck W, Stahnke N, et al. Estrogen treatment in tall girls. Acta Paediatr Scand. 1977;66:161-167.
25.
25. Frasier SD, Smith FG Jr. Effect of estrogens on mature height in tall girls: a controlled study. J Clin Endocrinol Metab. 1968;28:416-419.
26.
26. Sorgo W, Scholler K, Heinze F, et al. Critical analysis of height reduction in estrogen-treated tall girls. Eur J Pediatr. 1984;142:260-265.
27.
27. Sotos JF, MacGuillivray M, Peebles T, Crawford JF. The use of estrogen to curtail excessive height in constitutionally tall girls. J Pediatr. 1967;70:676-676.
28.
28. Normann EK, Trygstad O, Larsen S, Dahl-Jorgensen K. Height reduction in 539 tall girls treated with three different dosages of ethinyloestradiol. Arch Dis Child. 1991;66:1275-1278.
29.
29. Joss EE, Zeuner J, Zurbrugg RP, Mullis PE. Impact of different doses of ethinyl oestradiol on reduction of final height in constitutionally tall girls. EurJPediatr. 1994;153:797-801.
30.
30. Wiedemann E, Schwartz E. Suppression of growth hormone-dependent human serum sulfation factor by estrogen. J Clin Endocrinol Metab. 1972; 34:51-58.
31.
31. Royal College of General Practitioners Oral Contraceptive Study. Oral Contraceptives, venous thrombosis, and varicose veins. J R Coll Gen Pract. 1978;28:393-399.
32.
32. Helmrich SP, Rosenberg L, Kaufman DW, et al. Venous thromboembolism in relation to oral contraceptive use. Obstet Gynecol. 1987;69:91-95.
33.
33. Bottiger LE, Bomar? G, Eklund G, Westerholm B. Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content. Lancet. 1980;1:1097-1101.
34.
34. Werder EA, Waibel P, Sege D, Flury R. Severe thrombosis during oestrogen treatment for tall stature. EurJPediatr. 1990;149:389-390.
35.
35. Svan H, Ritzen EM, Hall K,Johansson L. Estrogen treatment of tall girls: dose dependency of effects on subsequent growth and IGF-I levels in blood. Acta Paediatr Scand. 1991;80: 328-332.
36.
36. Petrykowski W, Schmidt B. High dose conjugated estrogens do not reduce antithrombin III activity in tall girls. Horm Metab Res. 1983; 15:412-412.
37.
37. Grilters A, Heiderman P, Schluder H, et al. Effects of different oestrogen doses on final height reduction in girls with constitutional tall stature. EurJPediatr. 1989;149:11-13.
38.
38. Bartsch O, Weschke B, Weber B. Oestrogen treatment of constitutionally tall girls with 0.1 mg/day ethinyl oestradiol. Eur J Pediatr. 1988; 147:59-63.
39.
39. Schoenle EJ, Theintz G, Torresani T, et al. Lack of bromocriptine-induced reduction of predicted height in tall adolescents. J Clin Endocrinol Metab. 1987;65:355-358.
40.
40. Tauter MT, Tauber JP, Vigoni F, et al. Effect of the long-acting somatostatin analogue SMS 201-995 on growth rate and reduction of predicted adult height in ten tall adolescents. Acta Paediatr Scand. 1990;79:176-181.
41.
41. Hindmarsh PC, Pringle PJ, De Silvio L, Brook CG. A preliminary report on the role of somatostatin analogue (SMS 201-995) in the management of children with tall stature. Clin Endocrinol. 1990;32:83-91.
42.
42. Morange I, DeBoisvilliers F, Chanson P, et al. Slow release lanreotide treatment in acromegalic patients previously normalized by octreotideJ Clin Endocrinol Metab. 1994;79:145-151.
43.
43. Marek J, Hana V, Krsek M, et al. Long-term treatment of acromegaly with the slow-release somatostatin analogue lanreotide. EurJ Endocrinol. 1994;131:20-26.
44.
44. Heron I, Thomas F, Dero M, et al. Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog. Presse Med. 1993; 22:526-531.
45.
45. Skovby F, McKusick VA. Estrogen treatment of tall stature in girls with the Marfan syndrome. Birth Defects. 1977;13:155-161.
46.
46. Zachmann M, Ferrandez A, Mfirset G, et al. Testosterone treatment of excessively tallboys.JPediatr. 1976;88:116-123.
47.
47. Traupe H, von Muhlendahl KE, Bramswig J, Happle R. Acne of the fulminans type following testosterone therapy in three excessively tall boys. Arch Dermatol. 1988;124:414-417.
48.
48. Bramswig JH, von Lengerke HJ, Schmidt H, Schellong G. The results of short-term (6 months) high-dose testosterone treatment on bone age and adult height in boys of excessively tall stature. Eur J Pediatr. 1988;148:104-106.
49.
49. Lemcke B, Zentgraf J, Behre HM, et al. Long term effect on testicular function of high dose testosterone treatment for excessively tall stature. J Clin Endocrinol Metab. 1996;81:296-301.
50.
50. Schwarz HP, Joss EE, Zuppinger KA. Bromocriptine treatment in adolescent boys with familial tall stature: a pair-matched controlled studyJ Clin Endocrinol Metab. 1987;65:136-140.
51.
51. Tuddenhan RD, Snyder MM. Physical Growth of California Boys and Girls form Birth to Eighteen Years. Berkley: University of California Press; 1954. Overnutrition-Obesity
52.
52. Garn SM, Clark DC, Guire KE. Level of fatness and size attainment. Am J Phys Anthropol. 1973;40:447-450.
53.
53. Vignolo M, Naselli A, Di Battista E, et al. Growth and development in simple obesity. Eur J Pediatr. 1988;147:242-244.
54.
54. Forbes GB. Nutrition and growth.J Pediatr. 1977;91:40-42.
55.
55. Dietz WH, Hartung R. Changes in height velocity of obese preadolescents during weight reduction. Am J Dis Child. 1985;139:705-707.
56.
56. Epstein LH, Valoski A, McCurley J. Effect of weight loss by obese children on long-term growth. Am J Dis Child. 1993;147:1076-1080.
57.
57. Dunkel L, Sorva R, Voutilainen R. Low levels of sex hormone-binding globulin in obese children. J Pediatr. 1985;107:95-97.
58.
58. Glass AR. Endocrine aspects of obesity. Med Clin North Am. 1989;73:139-160.
59.
59. Strain GW, Zumoff B, Kream J, et al. Mild hypogonadotropic hypogonadism in obese men. Metabolism. 1982;31:871-875.
60.
60. Stanik S, Dornfeld LP, Maxwell MH, et al. The effect of weight loss on reproductive hormones in obese men. J Clin Endocrinol Metab. 1981;53:828-832.
61.
61. Strain GW, Zumoff B, Miller LK. The influence of massive weight loss on the hypogonadotropic hypogonadism of obese men. Int J Obesity. 1987;11(Suppl 2):54-59.
62.
62. Hartz AJ, Barboriak PN, Wong A, et al. The association of obesity with infertility and related menstrual abnormalities in women. Int J Obesity. 1979;3:59-73.
63.
63. Pasquali R, Casimirri F, Venturgli S, et al. Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels. Acta Endocrinol. 1983;104:110-116.
64.
64. Poretsky L, Kalin MF. The gonadotropic function of insulin. Endocr Rev. 1987;8:132-141.
65.
65. Underwood LE, Smith EP, Clemmons DR; et al. The production and actions of insulin-like growth factors: their relationship to nutrition and growth. In: Tanner JM, ed. Perspectives in the Science of Growth and Development. London: Smith Gordon; 1989;235-249.
66.
66. Forbes GB, Brown MR, Welle SL, Underwood LE. Hormonal response to overfeeding. Am J Clin Nutr. 1989;49:608-611.
